Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Martin Shkreli Loses Criminal Conviction Appeal

Martin Shkreli will continue to reside in federal prison after the notorious “Pharma Bro” failed to win an appeal to his 2017 criminal conviction for securities fraud and conspiracy to commit fraud.

Read More »

Roche and Novo Nordisk Top Clinical Trial Transparency Survey

In the third installment of the Good Pharma Scorecard, Roche and Novo Nordisk scored perfect marks in overall trial transparency.

Read More »

Gilead Snaps up Antiviral Programs From Novartis

Gilead Sciences struck a deal with Swiss pharma giant Novartis for three preclinical antiviral programs aimed at the treatment of human rhinovirus, influenza and herpes viruses.

Read More »

Bayer, Bristol-Myers, Ono Partner for Colorectal Cancer Study

Bayer, Bristol-Myers Squibb and Ono Pharmaceutical teamed up to study the most common type of metastatic colorectal cancer.

Read More »

Genmab Raises $506 Million in IPO

Copenhagen, Denmark-based Genmab A/S raised $506 million with an initial public offering (IPO), with the company trading on the Nasdaq under the ticker symbol GMAB.

Read More »

China Has Big Presence in Top 10 Biotech IPOs in 2019

New rules went into effect during 2018 on the Hong Kong stock exchange allowing companies that did not have a product on the market or generate revenue to list on the exchange.

Read More »

Inovio, Amneal Slash Workforce as Both Companies Undergo Realignments

Inovio Pharmaceuticals is terminating 28 percent of the company’s workforce, and Amneal Pharmaceuticals will cut 550 employees by the end of 2020.

Read More »

Three Senators Draft Bipartisan Resolution on CRISPR Gene Editing

Three U.S. senators introduced a resolution in support of a moratorium and other limits on gene editing embryos.

Read More »

Genentech Strikes Three Drug Discovery Deals

In a deal-making morning for South San Francisco-based Genentech, the Roche subsidiary struck three separate transactions with small companies to boost drug development.

Read More »

Artificial Intelligence-Focused Companies Advance Programming

Companies continue to announce advancements in artificial intelligence programming as they harness the power of AI and machine learning to aid in drug discovery and development.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom